McLain Offers Advice on Preparing a Winning Opening Statement in The Daily Journal Byline
19 February 2020
Partner Byron McLain published “Top 10 Tips for Preparing and Presenting Your Opening Statement at Trial” in the Daily Journal.
According to McLain, as lawyers deliver their opening statements, they should always feel that every trial is winnable. And winning begins with preparation and presentation of opening statements.
McLain’s tips for preparing a winning opening statement include:
- Outline your statement
- Recite your opening statement multiple times alone
- Show confidence in what you are saying
- Recite your opening statement to someone who is NOT a lawyer
- Avoid reading your opening statement
- Provide visuals in your opening statements
- Outline for the jury where you are going
- Trust the jury with your bad facts
- Explain why a decision for your client is right
- Ask for what you want
Before joining Foley, McLain served as the Health Care Fraud Coordinator in the Major Frauds Section of the U.S. Attorney’s Office in Los Angeles. He is a member of Foley’s Government Enforcement Defense & Investigations Practice and works closely with the firm’s Health Care, Cannabis and Sports & Entertainment Industry Teams.
People
Related News
25 July 2024
In the News
Donald Schroeder on Groff – ‘Supreme Court decision is inviting a more fact-based analysis’
Foley & Lardner LLP partner Donald Schroeder assessed the impact of the U.S. Supreme Court’s 2023 decision in a religious accommodation case as it returns to the district court in the Law360 article, “A Year After High Court Spotlight, Groff Case Still A Bellwether.”
24 July 2024
In the News
Louis Lehot Featured in Q&A on How Startups Can Prepare for IPO
Foley & Lardner LLP partner Louis Lehot features in the Q&A, "How startups can get in top shape for an IPO, according to Silicon Valley lawyer Louis Lehot," part of Business Insider's Road to IPO' series.
24 July 2024
In the News
Courtenay Brinckerhoff on Patent Cap in Drug Pricing – ‘Hard to predict if this will make a difference’
Foley & Lardner LLP partner Courtenay Brinckerhoff discussed a recent bill passed in the U.S. Senate aimed at lowering drug prices by limiting the number of patents that can be asserted in cases over biosimilars in the Law360 article, “Patent Cap In Drug Pricing Bill Seen As Having Muted Effect.”